Glenmark Pharma share jumps as S&P Global upgrades rating from stable to positive
Positive S&P on Glenmark Pharma. S&P changed the company's outlook from stable to positive. Outlook improved due to sale of 75% stake in Glenmark Life
Written By: Zee Business Video Team